Januvia sitagliptin regulatory update

EMEA's CHMP issued a positive opinion to extend the indication of Januvia sitagliptin to include treatment with a sulfonylurea, and a sulfonylurea plus metformin. In the EU, the dipeptidyl peptidase-...